Calendario eventi - Corsi e congressi 2013
Highlights in the management of breast cancer
10 maggio 2013
Sede del Corso:
Domus Nova Bethlem - Roma
Vedi la BrochureRAZIONALE
Breast cancer represents one of the most serious problems of oncology, being the leading cause
of death of women in many countries. The present course will consolidate and integrate the
varied aspects of the multidisciplinary care of breast cancer of main interest to surgeons,
radiotherapists, medical oncologists, endocrinologists and cell
biologists working in this fi eld.
Particular attention will be given to the diagnosis and management of early and locally advanced
breast cancer, focusing on new neoadjuvant approaches and on the issues related to nipple
sparing/skin sparing mastectomy as well as radiation therapy and breast reconstruction.
A very interesting session of the course will cover the current controversies in the treatment of
ductal carcinoma in situ, where still no consensus has been reached on optimal management, and
questions related to the multidisciplinary treatment of very young and very old women with a
breast cancer diagnosis.
Specifi c focus will be devoted to the current status and advances in management of hormone
responsive, HER2 positive breast cancer and triple negative disease in the adjuvant as well as in
the advanced setting.
The meeting beyond providing breast radiologists, radiotherapists, medical
oncologists, surgeons, and fellows with an exhaustive overview on the various aspects
(biological, molecular and therapeutic) linked to breast cancer management, will also give the
opportunity to discuss controversial aspects with recognized experts in the field.
PROGRAMMA
10.00 - 13.00
Early disease
Current state of breast cancer classification
(M. Mottolese, Roma)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
Molecular tools for decision making in adjuvant therapy
(E. Ricevuto, L’Aquila)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
Current status of adjuvant HER-2 targeting therapy
(V. Guarneri, Modena)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
13.00 - 14.00
LUNCH
14.00 - 16.30
Locally advanced and metastatic disease
Overcoming treatment resistance in HER2-positive breast cancer
(F. Puglisi, Udine)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
Endocrine resistance: molecular pathways and rational development of targeted therapies
(G. Arpino, Napoli)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
Nanoparticles incapsulated drugs
(A. Fabi, Roma)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
Eribulin mesylate (E7389): review of efficacy and tolerability
(J. Foglietta, Perugia)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
How to improve the outcome of TNBC
(C. Bighin, Genova)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
Novel HER-2 targeting agents
(C. Natoli, Chieti)
B SERIE DI RELAZIONI SU TEMA PREORDINATO
